BI

BioAdvance — Seed VC Firm ($250K–$1.0M Checks)

VC
Philadelphia, PAWebsite

BioAdvance is a Seed venture capital firm based in Philadelphia, PA investing in Healthcare. The firm typically writes $250K–$1.0M checks and has 23 portfolio companies in our records.

Check size
$250K–$1.0M
Portfolio
23 companies on record
Partners
3 listed
Stage
Seed
Sectors
Healthcare
HQ
Philadelphia, PA
AUM
Not in our records

Last verified: 2026-09-03

How to approach: warm intro preferred
Stage

Seed

Check Size

$250K – $1.0M

Portfolio

23+ companies

Team

3 partners

Investor activity
Investments in last 12 months: 0

Investment Thesis

Invests in early-stage life sciences companies with potential for high impact in health and biotechnology.

How BioAdvance invests

BioAdvance is a vc firm based in Philadelphia, PA. The firm invests at the Seed stage, with a focus on Healthcare. It does not invest in Consumer, Media.

BioAdvance typically writes checks of $250K–$1.0M per investment.

BioAdvance has backed 23 companies in our records, including Halo Labs, ImmunoGenesis, IVIEW Therapeutics.

Partners & Team

BS

Barbara Schilberg

CEO

FJ

Frederick Jones

Advisory Partner

JM

Jeannette McClintock

Managing Director

HealthTech
BioTech

Industry Focus

Invests In

Healthcare

Does Not Invest In

Consumer
Media

Portfolio Companies (23)

Other

HA

Halo Labs

IM

ImmunoGenesis

IV

IVIEW Therapeutics

LA

Latus Bio

Uses next-generation AAV capsid technology for CNS disorders

OS

Ossianix

BioAdvance follow-on investment

PA

Palvella Therapeutics

ST

Strados Labs

TO

Tolerance Bio

Pioneers thymus restoration therapies to improve immune health and longevity

VI

Vittoria Biotherapeutics

KE

Keriton, Inc. (CIK 0001690238)

SEC Form D filing mentioning BioAdvance

How to pitch BioAdvance
  • •Raising at Seed? You're squarely in their sweet spot.
  • •Lead with your fit in Healthcare — the sectors they actively back.
  • •Size your ask to their typical $250K – $1.0M check.
  • •warm intro preferred
  • •Address your outreach to a specific partner, such as Barbara Schilberg, CEO.
  • •A warm introduction beats a cold email. Get matched and request an intro.

Featured In

Browse More Investors

Fundraising resources

Frequently Asked Questions

See if BioAdvance is a match for your startup

Upload your pitch deck to see how well you match with BioAdvance and 10,000+ other investors.

Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT

Is this your profile? Request a correction or removal